Data Mining in the US using the Vaccine Adverse Event Reporting System

By Iskander John  

Drug Safety, Vol. 29, Iss. 5, 2006-01 ,pp. : 375-384

Adis International

Access to resources Recommend Favorite

Antimicrobials and the Risk of Torsades de Pointes: The Contribution from Data Mining of the US FDA Adverse Event Reporting System

By Poluzzi Elisabetta  

Drug Safety, Vol. 33, Iss. 4, 2010-04 ,pp. : 303-314

Adis International

Access to resources Recommend Favorite

Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System: Disposition of Events Identified and Impact on Product Safety Profiles

By Bailey Steven   Singh Ajay   Azadian Robert   Huber Peter   Blum Michael  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite

A review of the Vaccine Adverse Event Reporting System database

By Geier David A   Geier Mark R  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 691-698

Informa Healthcare

Access to resources Recommend Favorite

Drug-versus-Drug Adverse Event Rate Comparisons: A Pilot Study Based on Data from the US FDA Adverse Event Reporting System

By Hochberg Alan M.   Pearson Ronald K.   O'Hara Donald J.   Reisinger Stephanie J.  

Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. : 137-146

Adis International

Access to resources Recommend Favorite